Prasinezumab

4 trials 2 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

11 Countries

Phase III

Phase II/III

Phase II

Phase III: 1 Phase II/III: 1 Phase II: 2

Indications tested

Parkinson's disease 4

Sponsors using this IMP

F. Hoffmann-La Roche AG 3 Universitaetsklinikum Tuebingen AöR 1

All trials

4 total

A randomized, double-blind, placebo-controlled, 104-week proof-of-concept study to evaluate the efficacy of intravenous prasinezumab in part… Pending

2024-513496-40-00 Phase II 6 countries Universitaetsklinikum Tuebingen AöR
A Study to Compare the Efficacy and Safety of Prasinezumab with a placebo in Participants with Early-Stage Parkinson’s Disease Recruiting

2025-522683-32-00 Phase III 9 countries F. Hoffmann-La Roche AG
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease (PASADENA) Recruiting

2023-504472-24-00 Phase II 4 countries F. Hoffmann-La Roche AG
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease Ended

2023-507132-21-00 Phase II/III 6 countries F. Hoffmann-La Roche AG

Showing 1–4 of 4 trials

← All drugs A–Z